The target population in phase I clinical trials of cholinergic compounds in Alzheimer disease: the role of the "bridging study". (Q46175723)
Jump to navigation
Jump to search
scientific article published in January 1995
Language | Label | Description | Also known as |
---|---|---|---|
English | The target population in phase I clinical trials of cholinergic compounds in Alzheimer disease: the role of the "bridging study". |
scientific article published in January 1995 |
Statements
The target population in phase I clinical trials of cholinergic compounds in Alzheimer disease: the role of the "bridging study" (English)
Cutler NR